PROVIDER INITIATED TEST - The CEA (Carcinoembryonic Antigen) test measures the level of CEA, a protein that may be elevated in certain types of cancer. It is most commonly used to monitor treatment response, assess disease progression, or detect recurrence in individuals with a known cancer diagnosis, particularly colorectal, pacreatic, gastric, lung and breast cancer.
CEA levels can also be elevated in non-cancerous conditions such as smoking, inflammation, liver disease, or infections. Because of this, results are interpreted alongside clinical findings and other diagnostic tests rather than used as a standalone screening tool.
CEA
PROVIDER INITIATED TEST - The CEA (Carcinoembryonic Antigen) test measures the level of CEA, a protein that may be elevated in certain types of cancer. It is most commonly used to monitor treatment response, assess disease progression, or detect recurrence in individuals with a known cancer diagnosis, particularly colorectal, pacreatic, gastric, lung and breast cancer.
CEA levels can also be elevated in non-cancerous conditions such as smoking, inflammation, liver disease, or infections. Because of this, results are interpreted alongside clinical findings and other diagnostic tests rather than used as a standalone screening tool.
